Detalhe da pesquisa
1.
Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.
Eur Respir J
; 51(3)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545318
2.
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.
Eur Respir J
; 52(4)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262574
3.
Cannabis use and lung cancer: time to stop overlooking the problem?
Eur Respir J
; 57(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33509956
4.
Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504.
Eur Respir J
; 46(5): 1440-50, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26381515
5.
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study.
Target Oncol
; 17(6): 675-682, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129569
6.
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.
Nat Med
; 28(2): 315-324, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115705
7.
EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy.
Cancers (Basel)
; 13(20)2021 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34680280
8.
Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases.
Lung Cancer
; 150: 21-25, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33045465
9.
High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study.
J Thorac Oncol
; 15(1): 120-124, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605799
10.
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.
Lung Cancer
; 137: 149-156, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31600593
11.
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer.
ERJ Open Res
; 4(2)2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29692997
12.
Lorlatinib - Induced pulmonary arterial hypertension.
Lung Cancer
; 120: 60-61, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748016
13.
Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients.
ERJ Open Res
; 4(1)2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29450203
14.
Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
Lung Cancer
; 58(1): 50-8, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17624475
15.
Lung cancer in renal transplant recipients: A case-control study.
Lung Cancer
; 111: 96-100, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838407
16.
Improvement of psoriasis in a lung cancer patient treated with erlotinib.
Eur J Dermatol
; 20(2): 243-4, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20123646
17.
Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature Review.
J Thorac Oncol
; 10(8): 1148-55, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26200268
18.
Detection of pelvic vein thrombosis by magnetic resonance angiography in patients with acute pulmonary embolism and normal lower limb compression ultrasonography.
Chest
; 122(1): 115-21, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12114346
19.
Lung cancer in patients with HIV Infection and review of the literature.
Med Oncol
; 21(2): 109-15, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15299182